| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Sorensen Mel is a President And CEO at Galera Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 2 sells.
Estimated insider holdings value: $17K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | GRTX Galera Therapeutics, Inc. | President And CEO | Sell | 70,000 | $0.02 | $1,407.00 | -26.4% | |
| Aug 16, 2024 | GRTX Galera Therapeutics, Inc. | President And CEO | Sell | 67,015 | $0.07 | $4,825.08 | -20.2% | |
| Mar 10, 2023 | GRTX Galera Therapeutics, Inc. | President And CEO | Buy | 100,000 | $1.68 | $168,120.00 | +43.1% |